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Edited by Sandro SonninoAbstract The 12/15-lipoxygenase (12/15-LOX) pathways of
arachidonate metabolism have been implicated in the pathogene-
sis of psoriasis. Since UV photo-therapy is a commonly used
technique for inhibiting cell proliferation and inﬂammation in
skin diseases, we hypothesized that UV-irradiation may aﬀect
12/15-LOX expression which might regulate cell proliferation.
In this study, we showed that UV-irradiation suppressed 12-
LOX expression, whereas up-regulated 15-LOX expression.
Treatment with the 15-LOX metabolites suﬃciently suppressed
insulin-like growth factor II-induced 12-LOX expression and
blocked cell cycle progression. On the basis of our ﬁndings, we
think that the 15-LOX metabolites may inhibit epidermal hyper-
plasia in psoriasis by regulating 12-LOX expression.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Lipoxygenase (LOX), as a family of dioxygenase, is involved
in arachidonate acid (AA) metabolism; a number of LOX
activities have been detected in human skin. Mammalian
lipoxygenase are classiﬁed as 5, 12, and 15 LOX. 12/15-
Lipoxygenase (12/15-LOX) pathways have been implicated in
the pathology of psoriasis. A 12-LOX metabolite, 12-hydrox-
yeicosatetraenoic acid (12-HETE) was elevated in psoriatic
skin lesions compared to the skin of normal individuals. It
has been demonstrated that baicalein (12-LOX inhibitor) or
12-LOX-speciﬁc anti-sense oligonucleotide induced apoptosis
in a carcinoma cell line via bcl-2 downregulation [1]. There-
fore, 12-LOX may play an essential role as a regulator for cell
survival. In contrast to 12-LOX, 15-LOX inhibits cell growth
via the p38 pathway [2]. 15-LOX exists in two isoforms, 15-
LOX-1 and 15-LOX-2, which are structurally and functionally
related. Both isoforms are known to regulate the production of
fatty acid hydroperoxides [3,4]. 15-LOX-1 is the main enzyme
that metabolize linoleic acid into 13-hydroxyoctadecadienoic
acid (13-HODE) [5,6], while the 15-LOX-2 enzyme mainlyAbbreviations: IGF-II, insulin-like growth factor II; 12/15-LOX,
12/15-lipoxygenase; PUVA, psoralen plus ultraviolet A
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[4]. The two iso-enzymes of 15-LOX appear to exert important
anti-carcinogenic eﬀects through the metabolism of polyunsat-
urated fatty acids [4]. 12/15-LOX enzymatic balance in the
metabolic pathway of linoleic acids and AA is believed to play
a role in the pathogenesis of skin disorders by acting as a reg-
ulator of cell proliferation and apoptosis. UV-irradiated
photo-therapy is a commonly used method to treat a variety
of skin diseases. However, the speciﬁc molecular function of
12/15-LOX balance in psoriatic hyperplasia remains to be
investigated, particularly with regard to UV-dependent
12/15-LOX gene expression. Therefore, in this study, we
attempted to examine the eﬀects of UV on 12/15-LOX gene
expression in the human keratinocyte cell line, HaCaT.2. Materials and methods
2.1. Materials
Dulbeccos modiﬁed Eagles medium (DMEM), fetal bovine serum
(FBS), and antibiotics (penicillin/streptomycin) were purchased from
Gibco BRL (Rockville, MD, USA). Anti-12-LOX (murine leukocyte)
polyclonal antiserum and 15-LOX metabolites were purchased from
Cayman Chemical (Ann Arbor, MI, USA). Anti-cyclin and anti-cdc
antibodies were purchased from Cell Signaling Technology (Danvers,
MA, SA). The Western blotting luminol reagent and anti-actin anti-
body were purchased from Santa Cruz Biotechnology (SantaCruz,
CA, USA). [3H]-thymidine was purchased from NEN (Boston, MA,
USA) and recombinant mouse insulin-like growth factor II (IGF-II)
from R&D Systems (Minneapolis, MN, USA).2.2. HaCaT cell culture
The immortalized human keratinocyte cell line HaCaT was kindly
provided by Prof. N. Fusenig (German Cancer Research Center, Ger-
many). The cells were maintained as a monolayer culture in DMEM
supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/ml
streptomycin at 37 C in a humidiﬁed atmosphere with 5% CO2. The
cells were then seeded at a density of 1 · 106 cells/100-mm dish. After
48 h, the cells were washed with serum-free medium; the medium
was replaced with one lacking FBS at least 24 h prior to the experi-
ments.
2.3. Quantitative RT-PCR
Total RNA was isolated from the cells by using Trizol Reagent from
Invitrogen (Carlsbad, CA, USA) according to the manufacturers
instructions. cDNA was synthesized by using Quantifect Reverse Tran-
scription Kit (Quiagen, Hilden, Germany). For Q-PCR, SYBR Premix
Ex Tag (Takara) was mixed with each primer, RNase-free H2O and
cDNA for a ﬁnal reaction volume of 20 ml. The following parameters
were used for real-time PCR: 95 C for 10 min, followed by 50 cycles of
95 C for 20 s, 55 C for 30 s and 72 C for 20 s. All experiments were
done in triplicate and normalizing GAPDH expression. Primers:
12-LOX primers 5 0-AGTTCCTCAATGGTGCCAAC-30 (forward),blished by Elsevier B.V. All rights reserved.
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5 0-GCGCTGCGGCTCTGGGAAATC-3 0 (forward), 5 0-AGAAGTG-
GACGTGGCCGGTTGTG-30 (reverse); 15-LOX2 primers 5 0-TGCC-
TCTCGCCATCCAGCT-30 (forward), 5 0-TCATGGAAGGAGAA-
CTCGGCAT-3 0 (reverse); cyclin D1 primers 5 0-ATGGAACACCA-
GCTCCTGTGCT-30 (forward), 5 0-TAGTTCATGGCCAGCGGGA-
AGA-3 0 (reverse); Cdk4 primers 5 0-ATGGCTACCTCTCGATATG-
AGC-30 (forward), 50-CTCAAAAGCCTCCAGTCGCCTC-30 (reverse).2.4. Western blot analysis
The cells was lysed with radioimmunoprecipitation assay (RIPA)
buﬀer (2 mM ethylenediaminetetraacetic acid (EDTA), 137 mM NaCl,
20 mM Tris–HCl (pH 8.0), 1 mM sodium vanadate, 10 mM NaF,
1 mM phenylmethylsulfonyl ﬂuoride (PMSF), 1% Triton X-100, 10%
glycerol, and a protease inhibitor cocktail) and harvested immediately.
The samples were loaded onto sodium dodecyl sulfate (SDS)–poly-
acrylamide gels for electrophoresis and subsequently transferred onto
polyvinylidene ﬂuoride membranes obtained from Millipore (Bedford,
MA, USA). After blocking, the membranes were incubated overnight
at 4 C along with speciﬁc primary antibodies with gentle agitation.
After washing, the membranes were incubated with a horseradish per-
oxidase (HRP)-conjugated secondary antibody for 1 h at room tem-
perature. Bands were detected by using ECL Plus Western blotting
detection reagents from Amersham Biosciences Co. (Piscataway, NJ,
USA).2.5. [3H]-Thymidine incorporation
The cells were cultured in growth medium in 96-well plates
(3 · 103 cells/well) and serum starved by culturing them in serum-free
DMEM for 24 h. They were then pretreated with 15-LOX metabolites
in serum-free DMEM for 24 h. Four hours prior to collecting the cells,
they were pulsed with [3H]-thymidine (0.5 lCi/well) in modiﬁed Eagles
medium containing Eagles balanced salt solution and the same addi-
tives as those used in the prepulse period. The cells were then washed
three times with phosphate-buﬀered saline (PBS); cellular DNA was
precipitated with 10% trichloroacetic acid (TCA) at 4 C for 30 min
and solubilized in 0.1 N NaOH for 30 min. The incorporation of
[3H]-thymidine in the cellular DNA was measured by adding scintilla-
tion ﬂuid and determining the counts per minute in a scintillation
counter.2.6. Cell cycle and apoptosis analysis
The cells were harvested and washed with ice-cold phosphate-buf-
fered saline (PBS). The pellets were resuspended in 70% ethanol, andFig. 1. UV-irradiation decreased 12-LOX expression in keratinocytes. (A) U
treated with the indicated dose of UVB for 24 h. The mRNA levels were de
measured by Western blot analysis after exposure to UVB and UVA for 24 h
exposed to a low dose of UVA with or without 100 ng/ml of psoralen (100 nthen stored on ice. The cells were then permeabilized in a reagent con-
sisting of 0.05% Triton X-100 and RNaseA (100 lg/ml) in PBS. Fixed
cells were stained with a propidium iodide (50 lg/ml), and cell cycle
phase distribution was analysed using a Becton Dickinson FACScan
ﬂow cytometer (San Jose, CA, USA).
2.7. UVB irradiation of HaCaT cells
The serum-starved monolayer cultures were irradiated with a bank
of two FS20 Lamps (National Biological, Twinsburg, OH) that emit
a continuous spectrum from 270 to 390 nm, with peak emission at
313 nm; approximately 65% of the radiation was within the UVB
(280–320 nm) range. The irradiance of a single bulb averaged 6.25 J/
m2/s at a tube-to-target distance of 8 cm, as measured with a spectro-
radiometer (model IL1700A; International Light Inc., Newburyport,
MA, USA). The HaCaT cells were irradiated with the UVB source
at 100 J/m2 in a minimum amount of PBS (about 3 ml) after washing
three times with PBS. Immediately after irradiation, the cells were cul-
tured in serum-free medium for the indicated times with or without
addition of drugs.3. Results and discussion
3.1. Eﬀect of UV-irradiation on 12-LOX gene expression
12-LOX and its metabolite 12(S)-HETE are key regulators
of tumor growth. 12-HETE was reported to be over expressed
in inﬂammatory skin diseases such as psoriasis, in which
hyperproliferation was observed. In contrast to 12-LOX,
UV-irradiation is a commonly used therapeutic method for
psoriasis patients in order to inhibit cell proliferation and
inﬂammation. Therefore, we investigated whether UV-irradia-
tion can aﬀect 12-LOX expression in keratinocyte, HaCaT. As
shown in Fig. 1, the level of 12-LOX expression was dose-
dependently decreased by UVB and UVA-irradiation
(Fig. 1A and B). Psoralen plus ultraviolet A (PUVA), UVA-
photochemotherapy is considered to be ﬁrst-line treatment
for patients with moderate to severe psoriasis. To investigate
whether PUVA can aﬀect 12-LOX expression, HaCaT cells
were treated with psoralen and low doses of UVA such as
2.5, 5, and 7.5 J/m2. Together with psoralen, the low dose of
UVA which alone cannot aﬀect 12-LOX expression could sig-VB suppresses the expression of 12-LOX mRNA. HaCaT cells were
termined by RT-PCR. (B) The 12-LOX protein levels in the cells were
. (C) PUVA treatment inhibits 12-LOX expression. HaCaT cells were
g/ml) for 24 h. Unit of UVAB dose: J/m2.
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results may indicate the successful PUVA-mediated inhibition
of cell growth and inﬂammation via decreased 12-LOX
expression.
3.2. Eﬀect of 15-LOX metabolites on 12-LOX gene expression
It has been reported that dermis-derived 15-HETE inhibits
epidermal 12-LOX activity [7]. However, the eﬀect of UV-irra-
diation on 15-LOX expression was not examined. Therefore,
under UVB-irradiation the mRNA expression of 15-LOX un-
der UVB-irradiation was measured. As shown in Fig. 2,
expression of both 15-LOX-1 and 15-LOX-2 were dose-depen-
dently increased in HaCaT cells. Furthermore, PUVA treat-
ment could signiﬁcantly increased 15-LOX expression
(Fig. 2B). Previously, we reported that IGF-II regulates the
12-LOX expression and promotes cell proliferation in human
keratinocytes [8]. Therefore, we next examined whether 15-
LOX metabolites can inhibit IGF-II-induced 12-LOX expres-
sion and keratinocytes proliferation. Diﬀerent 15-LOX metab-
olites such as 15-HETE, 15-HETrE and 13-HODE were
cultured with IGF-II and 12-LOX expression was measured.
As expected, 15-LOX metabolites signiﬁcantly inhibit IGF-
II-induced 12-LOX expression (Fig. 2C). Thus, the eﬀective
UV-irradiation or PUVA treatment might result from the
induction of 15-LOX activity and inhibition of 12-LOX
expression.Fig. 2. UV-irradiation increased 15-LOX expression and decreased 12-LOX e
mRNA were increased by UVB irradiation (A) or by PUVA treatment (B). H
24 h, the mRNA levels were measured by RT-PCR. (C) The expression of 12-L
13-HODE). HaCaT cells were treated with 30 lM of 15-LOX metabolites in
was subjected to Western blot analysis. Unit of UVA/B dose: J/m2; MO = 83.3. Inhibition of cell proliferation and induction of apoptosis by
15-LOX metabolites
A number of studies indicate the biological eﬀects of LOX,
such as the anti-tumor eﬀects of 15-LOX and its pathways
[9,10]. To better understand the role of 15-LOX metabolites
in cell proliferation, we examined their eﬀects on cell prolifer-
ation, assayed by thymidine incorporation. HaCaT cells trea-
ted with 15-LOX metabolites showed decreased thymidine
incorporation even with IGF-II treatment (Fig. 3A). Next,
we examined the synergic eﬀect of UV-irradiation and 15-
LOX activity, since this might prove useful in the treatment
of psoriasis patients. HaCaT cells were pretreated with 15-
LOX metabolites with or without UVB exposure for 24 h.
Treatment with 15-LOX metabolite signiﬁcantly enhance the
UVB-induced apoptosis (Fig. 3B). Thus, the combination of
15-LOX metabolites and UV-irradiation might be a useful
therapeutic tool to inhibit hyper-proliferation in the skin le-
sions of psoriasis patients.
3.4. Eﬀect of 15-LOX metabolites on the cell cycle molecules
Cell cycle progression from the G1 phase to the G2/M phase
is associated with the transcriptional activation by a cyclin/
CDK complex. Two cell cycle regulator complexes, cyclin D-
CDK4/6 and cyclin E-CDK2, have been shown to activate
Rb-E2F complex disassociation. Activated E2F induced cell
cycle progression to the G2/M phase through S-phase action.xpression through 15-LOX metabolites. The levels of 15-LOX-1 and its
aCaT cells were treated with diﬀerent doses of UVB or PUVA. After
OX was decreased by 15-LOXmetabolites (15-HETE, 15-HETrE, and
the presence or absence of IGF-II (100 lg/ml) for 24 h. The cell lysate
-MOP (psoralen).
Fig. 3. The 15-LOX metabolites decreased cell proliferation via enhanced apoptosis. (A) The 15-LOX metabolites inhibited cell proliferation.
HaCaT cells were treated with 30 lM of 15-LOX metabolites (15-HETE, 15-HETrE, and 13-HODE) in the presence or absence of IGF-II (100 lg/
ml) for 24 h. The level of cell proliferation was measured by a [3H]-thymidine incorporation assay. (B) The 15-LOX metabolites enhanced UVB-
induced apoptosis. Cells were stained with PI for an analysis of nuclear DNA content. HaCaT cells were exposed to UVB (100 J/m2) with 10 lM of
15-LOX metabolites for 24 h. The fragmentation of DNA in apoptotic cells was measured by ﬂow cytometry.
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LOX inhibitor, inhibits cell proliferation by arresting the G0–
G1 phase [11] and S-phase [12]. Therefore, we examined theFig. 4. Inhibition of cell cycle regulator by 15-LOX metabolites. (A) The 15-L
protein. HaCaT cells were treated for 24 h and the protein levels were measu
CDK4 were determined by RT-PCR. (C) The cells were treated with 13-HOD
by Western blotting.expression level of the cell cycle regulator under 15-LOX
metabolites treatment. The treatment signiﬁcantly decreased
the cyclin D and CDK4 expression (Fig. 4B). Further, the pro-OX metabolites (30 lM) suppressed the expression of the cyclin/CDK
red by Western blot analysis. (B) The mRNA levels of cyclin D1 and
E for the indicated time periods, and the cyclin D1 level was measured
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decreased by 15-LOX metabolites (Fig. 4A and C). Inhibition
of cyclin D and CDK4 are associated with S-phase accumula-
tion and may arrest the cell cycle. The decreased cyclin B1
expression may result in a disruption of E2F transcription
activity by cyclin–CDK inhibition. Thus, the cell cycle arrest
by 15-LOX metabolites is possibly caused by the inhibition
of 12-LOX activity.
In summary, the UV-irradiation induced the 15-LOX
expression but decreased 12-LOX expression was decreased.
Treatment with 15-LOX metabolites increased the cell cycle ar-
rest and apoptosis of human keratinocyte cells, possibly by
decreasing 12-LOX expression. Further, we observed PUVA-
mediated inhibition of 12-LOX and induction of 15-LOX
expression. This might be the eﬀect of PUVA-treatment on
psoriasis-aﬀected skin. Thus, the inhibition of 12-LOX expres-
sion is a reasonable therapeutic approach in the treatment of
hyperproliferative skin disease. The interruption of 12-LOX
catalytic activity and the 12-HETE signaling pathway by
increasing 15-LOX metabolites may be a promising target
for psoriasis therapies.
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